Brittney S Lange-Maia1,2, Aron S Buchman3,4, Sue E Leurgans3,4, Melissa Lamar3,5, Elizabeth B Lynch6, Kristine M Erlandson7, Lisa L Barnes3,4. 1. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA. Brittney_Lange-Maia@Rush.edu. 2. Department of Preventive Medicine, Rush University Medical Center, Chicago, IL, USA. Brittney_Lange-Maia@Rush.edu. 3. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA. 4. Department of Neurological Sciences Rush, University Medical Center, Chicago, IL, USA. 5. Department of Psychiatry & Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA. 6. Department of Preventive Medicine, Rush University Medical Center, Chicago, IL, USA. 7. Department of Medicine and Epidemiology, University of Colorado Anschutz Medical Center, Aurora, CO, USA.
Abstract
BACKGROUND: Older Black adults face a disproportionate burden of HIV prevalence, but less is known about racial disparities in age-related outcomes in HIV. We assessed the effect of HIV status and race on motor and pulmonary function, as well as how they contribute to mobility disability. SETTING: Community-based study; Chicago, IL METHODS: Participants were 363 community-dwelling adults age ≥ 50 years, 48% living with HIV, and 68% Black. Participants with HIV were recruited from a specialty HIV clinic, and participants without HIV (comparable on key demographic, lifestyle, and behavioral characteristics) were recruited from the community. Measures included motor function summarized by 10 motor performance measures, pulmonary function summarized by 3 measures assessed using handheld spirometry, and self-reported mobility disability. RESULTS: In fully adjusted linear models, HIV was associated with better motor (β = 9.35, p < 0.001) and pulmonary function (β = 16.34, p < 0.001). For pulmonary function, the effect of HIV status was moderated by race (interaction between Black race and HIV status: β = - 11.66, p = 0.02), indicating that better pulmonary function among participants with HIV was less evident among Black participants. In fully adjusted models, odds of mobility disability did not differ by race, HIV status, or pulmonary function; better motor function was associated with lower odds of mobility disability (OR = 0.91 per 1-point higher, 95% CI 0.88-0.93). CONCLUSION: Better motor and pulmonary function exhibited by participants with HIV could reflect access to medical care. Racial differences in lung function among participants with HIV indicate potential disparities in prevention or treatment of pulmonary disease or underlying risk factors.
BACKGROUND: Older Black adults face a disproportionate burden of HIV prevalence, but less is known about racial disparities in age-related outcomes in HIV. We assessed the effect of HIV status and race on motor and pulmonary function, as well as how they contribute to mobility disability. SETTING: Community-based study; Chicago, IL METHODS: Participants were 363 community-dwelling adults age ≥ 50 years, 48% living with HIV, and 68% Black. Participants with HIV were recruited from a specialty HIV clinic, and participants without HIV (comparable on key demographic, lifestyle, and behavioral characteristics) were recruited from the community. Measures included motor function summarized by 10 motor performance measures, pulmonary function summarized by 3 measures assessed using handheld spirometry, and self-reported mobility disability. RESULTS: In fully adjusted linear models, HIV was associated with better motor (β = 9.35, p < 0.001) and pulmonary function (β = 16.34, p < 0.001). For pulmonary function, the effect of HIV status was moderated by race (interaction between Black race and HIV status: β = - 11.66, p = 0.02), indicating that better pulmonary function among participants with HIV was less evident among Black participants. In fully adjusted models, odds of mobility disability did not differ by race, HIV status, or pulmonary function; better motor function was associated with lower odds of mobility disability (OR = 0.91 per 1-point higher, 95% CI 0.88-0.93). CONCLUSION: Better motor and pulmonary function exhibited by participants with HIV could reflect access to medical care. Racial differences in lung function among participants with HIV indicate potential disparities in prevention or treatment of pulmonary disease or underlying risk factors.
Authors: Stephanie Shiau; Alexis A Bender; Jane A O'Halloran; Erin Sundermann; Juhi Aggarwal; Keri N Althoff; Jason V Baker; Steven Deeks; Linda P Fried; Stephen Karpiak; Maile Y Karris; Thomas D Marcotte; Jean B Nachega; Joseph B Margolick; Kristine M Erlandson; David J Moore Journal: AIDS Res Hum Retroviruses Date: 2020-09-23 Impact factor: 2.205
Authors: S Duke Han; Oluwatoyin Adeyemi; Robert S Wilson; Sue Leurgans; Antonio Jimenez; Lawrence Oullet; Raj Shah; Alan Landay; David A Bennett; Lisa L Barnes Journal: Gerontology Date: 2017-01-27 Impact factor: 5.140
Authors: Loic Desquilbet; Lisa P Jacobson; Linda P Fried; John P Phair; Beth D Jamieson; Marcy Holloway; Joseph B Margolick Journal: J Gerontol A Biol Sci Med Sci Date: 2007-11 Impact factor: 6.053
Authors: Marcel Zwahlen; Ross Harris; Margaret May; Robert Hogg; Dominique Costagliola; Frank de Wolf; John Gill; Gerd Fätkenheuer; Charlotte Lewden; Mike Saag; Sholmo Staszewski; Antonella d'Arminio Monforte; Jordi Casabona; Fiona Lampe; Amy Justice; Viktor von Wyl; Matthias Egger Journal: Int J Epidemiol Date: 2009-10-09 Impact factor: 7.196
Authors: Cherise Wong; Stephen J Gange; Richard D Moore; Amy C Justice; Kate Buchacz; Alison G Abraham; Peter F Rebeiro; John R Koethe; Jeffrey N Martin; Michael A Horberg; Cynthia M Boyd; Mari M Kitahata; Heidi M Crane; Kelly A Gebo; M John Gill; Michael J Silverberg; Frank J Palella; Pragna Patel; Hasina Samji; Jennifer Thorne; Charles S Rabkin; Angel Mayor; Keri N Althoff Journal: Clin Infect Dis Date: 2018-04-03 Impact factor: 9.079
Authors: Christine S Autenrieth; Eduard J Beck; Dominik Stelzle; Christoforos Mallouris; Mary Mahy; Peter Ghys Journal: PLoS One Date: 2018-11-29 Impact factor: 3.240